The present invention related to novel polymorphic forms of Moxifloxacin hydrochloride and an improved industrially viable, cost effective process for their manufacturing.Linvention concerne de nouvelles formes polymorphes de chlorhydrate de moxifloxacine, ainsi quun procédé de fabrication amélioré, rentable et industriellement viable de ces nouvelles formes.